BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17318105)

  • 1. [Orbital involvement in IgD Kappa myeloma].
    Hassikou H; Tabache F; Safi S; Laktaoui A; Hadri L
    J Fr Ophtalmol; 2007 Feb; 30(2):e6. PubMed ID: 17318105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma with two monoclonal IgG and IgD in serum: a case report.
    Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
    Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgD kappa myeloma: a new case.
    Amine B; Benbouazza K; Harzy T; Rahmouni R; Guedira N; Lazrak N; Hajjaj-Hassouni N
    Joint Bone Spine; 2004 Jul; 71(4):331-3. PubMed ID: 15288860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
    Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma.
    Fujishima M; Komatsuda A; Imai H; Wakui H; Watanabe W; Sawada K
    Intern Med; 2003 Jan; 42(1):121-4. PubMed ID: 12583633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgD multiple myeloma with renal involvement: case report.
    Homan H; Ohtubo Y; Ito H; Azuma K; Yasumoto Y; Ohtuka H; Uomizu K; Yamashita W; Uemura S; Ohsaki K
    Jpn J Med; 1990; 29(2):212-5. PubMed ID: 2232370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescent and immunoperoxidase characteristics of IgDlambda myeloma involving the orbit.
    Knowles DM; Halper JA; Trokel S; Jakobiec A
    Am J Ophthalmol; 1978 Apr; 85(4):485-94. PubMed ID: 350049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An elderly patient with IgD myeloma associated with renal amyloidosis and acute renal failure].
    Kiyatake I; Tomino Y; Funabiki K; Kubokawa Y; Shirato I; Kubota M; Koide H
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):791-6. PubMed ID: 2511365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsecretory IgD (kappa) multiple myeloma. Report of a case and review of the literature.
    Kanoh T; Niwa Y
    Am J Clin Pathol; 1987 Oct; 88(4):516-9. PubMed ID: 3116837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgD myeloma manifesting as acute renal insufficiency].
    Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
    Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature.
    Tokunaga T; Hashimoto H; Yoshida Y; Sugimoto T; Mokuda S; Kosaka Y; Shimizu R; Hirata S; Kumagai T; Komoto K; Wada H; Sugiyama E
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):22-28. PubMed ID: 32985955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgD paraproteinemias.
    Tichý M; Matĕja F; Urban P; Matuska M
    Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A further case of IgD myeloma (author's transl)].
    Daunizeau A; Daunizeau A; Comyn F
    Sem Hop; 1979 Dec 8-15; 55(41-42):1941-3. PubMed ID: 231320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmic manifestations of atypical IgD multiple myeloma.
    Edmunds MR; Cikatricis P; Mukherji S; Bowyer JD
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22814986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.